Roche cat­a­pults Thomas Schi­neck­er to chief of di­ag­nos­tics unit

One day af­ter the FDA sanc­tioned the ac­cel­er­at­ed ap­proval of Roche’s lat­est an­ti­body-drug con­ju­gate, the Swiss drug­mak­er has un­veiled the new head of its $13 bil­lion di­ag­nos­tics unit.

Roche’s di­ag­nos­tics arm gen­er­at­ed CHF 12.9 bil­lion ($13 bil­lion) in sales last year. It sells a myr­i­ad of tests for blood, HPV, can­cer and di­a­betes and is dri­ven by its cen­tral­ized and point of care so­lu­tions busi­ness. The head of this well-per­form­ing unit — Thomas Schi­neck­er — is be­ing pro­mot­ed to CEO of Roche Di­ag­nos­tics, and will be­gin his tenure from Au­gust 1, the com­pa­ny said on Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER